Concepedia

Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study

Kazuyuki Numakura, Mizuki Kobayashi, Toshiya Ishida, Katsumi Okane, Kazumasa Suzuki, Naotake Shimoda, Takehiro Suzuki, Teruaki Kumazawa, Ryusei Sasaki, Hisami Fukuda,

European Urology Focus · 2022 · 15 citations · 17 references

DOI

Concepts

References

17

Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors

Álvaro Morales, David Eidinger, Andrew W. Bruce · The Journal of Urology · 1976 · 1.8K citations

, , +5

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

Donald L. Lamm, Brent A. Blumenstein, John D. Crissman et al. · The Journal of Urology · 2000 · 1.3K citations

, , +11

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales et al. · The Journal of Urology · 1992 · 795 citations

, , +8

Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

Jorg R. Oddens, Maurizio Brausi, Richard Sylvester et al. · European Urology · 2012 · 512 citations

, , +8

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

Richard Sylvester, Óscar Rodríguez, Virginia Hernández et al. · European Urology · 2021 · 463 citations

, , +10